Skip to Main Content

Paper Details

TD-92, a novel erlotinib derivative, depletes tumor-associated macrophages in non-small cell lung cancer via down-regulation of CSF-1R and enhances the anti-tumor effects of anti-PD-1.
Cancer Lett
10
2021
Author NameAffiliation
Yen-Lin ChenCardinal Tien Hospital, Fu Jen Catholic University
  • 1 - 1

Datasets

Release 1.2